Pharmaceutical Fair Market Value by kuc14289

VIEWS: 29 PAGES: 37

Pharmaceutical Fair Market Value document sample

More Info
									                   Statement Of Income (USD $)
                                                                        12 Months Ended
                                                                         Dec. 31, 2009
                  In Millions, except Per Share data
Net sales                                                                           $2,147.6
Cost of products sold                                                                1,057.7
Gross profit                                                                         1,089.9
Selling, general and administrative expenses                                              518.1
Research and development expenses                                                            63
Restructuring costs                                                                         9.2
Operating income                                                                          499.6
Interest, net                                                                                10
Income before income taxes                                                                489.6
Provision for income taxes                                                             142.9
Net income                                                                            $346.7
Weighted average number of shares outstanding - Basic (in millions)                       121.9
Weighted average number of shares outstanding - Diluted (in millions)                     123.7
Net income per share - Basic                                                              $2.84
Net income per share - Diluted                                                             $2.8
12 Months Ended           12 Months Ended
 Dec. 31, 2008             Dec. 31, 2007

            $2,200.7                  $2,038.7
             1,070.8                   1,002.7
             1,129.9                     1,036
                  561.6                     517.1
                   64.5                      59.3
                      0                         0
                  503.8                     459.6
                   14.3                        22
                  489.5                     437.6
                 148                     126.5
              $341.5                    $311.1
                  126.3                     130.6
                  128.8                     133.1
                   $2.7                     $2.38
                  $2.65                     $2.34
        Statement Of Financial Position Classified (USD $)
                                                                             Dec. 31, 2009
                                 In Millions
Current assets:
Cash and cash equivalents                                                                     $372.5
Accounts receivable                                                                            285.2
Inventories                                                                                      609
Deferred taxes                                                                                  53.3
Other current assets                                                                            63.5
Total current assets                                                                         1,383.5
Property, plant and equipment:
Land                                                                                              49
Buildings and improvements                                                                     694.7
Machinery and equipment                                                                        800.2
Construction in progress                                                                       107.9
Less - accumulated depreciation                                                              (942.9)
Property, plant and equipment, net                                                             708.9
Goodwill, net                                                                                  400.7
Intangibles, net                                                                               129.3
Other assets                                                                                    91.4
Total assets                                                                                 2,713.8
Current liabilities:
Notes payable and current maturities of long-term debt                                        476.5
Accounts payable                                                                              112.4
Payroll                                                                                          51
Income taxes                                                                                   42.2
Other                                                                                          59.8
Total current liabilities                                                                     741.9
Long-term debt                                                                                   100
Pension and post-retirement benefits                                                            93.9
Deferred taxes                                                                                  22.5
Other liabilities                                                                               69.5
Total liabilities                                                                            1,027.8
Stockholders' equity:
Common stock, $1.00 par value; 300.0 million shares authorized; 201.8
million shares issued at December 31, 2009 and 2008; 121.7 million and
122.1 million shares outstanding at December 31, 2009 and 2008,
respectively                                                                                  201.8
Capital in excess of par value                                                                152.8
Common stock in treasury, at cost, 80.0 million and 79.7 million shares at
December 31, 2009 and 2008, respectively                                                     (1,983)
Retained earnings                                                                            3,230.4
Accumulated other comprehensive income                                                            84
Total stockholders' equity                                                                     1,686
Total liabilities and stockholders' equity                                               $2,713.8
Dec. 31, 2008


                 $251.8
                  269.8
                  661.8
                   45.9
                   79.9
                1,309.2

                     49
                  674.6
                  757.5
                   41.4
                (862.1)
                  660.4
                  388.3
                  120.6
                     78
                2,556.5

                 528.8
                 114.6
                  58.6
                  41.1
                  50.8
                 793.9
                  200.1
                   92.6
                   18.6
                   72.1
                1,177.3




                 201.8
                   133

           (1,935.3)
             2,954.4
                25.3
             1,379.2
            $2,556.5
Statement Of Financial Position Classified (Parenthetical) (USD
                              $)
                                                                  Dec. 31, 2009
           Share data in Millions, except Per Share data
Common   stock, par value                                                            $1
Common   stock, shares authorized                                                   300
Common   stock, shares issued                                                     201.8
Common   stock, shares outstanding                                                121.7
Common   stock in treasury, shares                                                   80
Dec. 31, 2008

                   $1
                  300
                201.8
                122.1
                 79.7
            Statement Of Stockholders' Equity (USD $)


                                                                    Common Stock
                                In Millions
Beginning Balance at Dec. 31, 2006                                                  201.8
Beginning Balance at Dec. 31, 2006                                                 $201.8
Net income
Other comprehensive income - Foreign currency translation
Pension and Post Retirement
Unrealized gain (loss) on securities, net
Dividends ($.58 in 2009, $.52 in 2008 and $.46 in 2007 per share)
Shares exchanged for stock options
Exercise of stock options
Restricted stock grant
Stock-based compensation expense
Stock repurchases
Adjustment to initially apply FIN 48
Exercise of stock options
Stock repurchases
Ending Balance at Dec. 31, 2007                                                     201.8
Ending Balance at Dec. 31, 2007                                                     201.8
Net income
Other comprehensive income - Foreign currency translation
Pension and Post Retirement
Unrealized gain (loss) on securities, net
Adjustment to initially apply the measurement date features of
Statement of Financial Accounting Standards No. 158, net of tax
Dividends ($.58 in 2009, $.52 in 2008 and $.46 in 2007 per share)
Shares exchanged for stock options
Exercise of stock options
Restricted stock grant
Stock-based compensation expense
Stock repurchases
Exercise of stock options
Stock repurchases
Ending Balance at Dec. 31, 2008                                                     201.8
Ending Balance at Dec. 31, 2008                                                     201.8
Net income
Other comprehensive income - Foreign currency translation
Pension and Post Retirement
Unrealized gain (loss) on securities, net
Dividends ($.58 in 2009, $.52 in 2008 and $.46 in 2007 per share)
Shares exchanged for stock options
Exercise of stock options
Restricted stock grant
Stock-based compensation expense
Stock repurchases
Minority interest purchase
Exercise of stock options
Stock repurchases
Ending Balance at Dec. 31, 2009   $201.8
Ending Balance at Dec. 31, 2009    201.8
Capital in Excess of Par    Common Stock in
        Value                 Treasury               Retained Earnings

                                            69.8
                    $79.1             ($1,375.4)                   $2,424.7
                                                                      311.1




                                                                         (60)
                    (0.9)
                     17.3                       24
                      0.7                      1.6
                     13.5
                                         (184.3)
                                                                          3.5
                                           (1.4)
                                               4
                    109.7              (1,534.1)                    2,679.3
                                            72.4
                                                                     341.5




                                                                        (1)
                                                                     (65.4)
                    (0.6)
                       15                     18.1
                      1.6                      1.9
                      7.3
                                         (421.2)
                                             (1)
                                             8.3
                      133              (1,935.3)                    2,954.4
                                            79.7
                                                                     346.7




                                                                     (70.7)
                    (0.9)
                     14.5                     16.5
                      2.1                        3
                      6.4
                                          (67.2)
                    (2.3)
             (1.1)
               1.4
$152.8   ($1,983)    $3,230.4
                80
Accumulated Other
  Comprehensive
 Income/(Loss)          Total


               $80.7            $1,410.9
                                   311.1
                 71.5                71.5
                  8.4                 8.4
                (0.7)               (0.7)
                                     (60)
                                    (0.9)
                                     41.3
                                      2.3
                                     13.5
                                 (184.3)
                                      3.5


               159.9             1,616.6

                                   341.5
               (86.4)             (86.4)
               (42.2)             (42.2)
                  (6)                (6)

                                     (1)
                                  (65.4)
                                   (0.6)
                                    33.1
                                     3.5
                                     7.3
                                 (421.2)


                25.3             1,379.2

                                   346.7
                55.4                 55.4
                 2.8                  2.8
                 0.5                  0.5
                                  (70.7)
                                    (0.9)
                                       31
                                      5.1
                                      6.4
                                  (67.2)
                                    (2.3)
$84   $1,686
   Statement Of Stockholders' Equity (Parenthetical) (USD $)
                                                                1/1/2009 -
                                                               12/31/2009

Dividends, per share                                                         $0.58
 1/1/2008 -            1/1/2007 -
12/31/2008            12/31/2007

              $0.52                 $0.46
             Statement Of Cash Flows Indirect (USD $)
                                                              12 Months Ended
                                                               Dec. 31, 2009
                              In Millions
Cash flows from operating activities:
Net income                                                                  $346.7
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization                                                    92.4
Deferred taxes                                                                  (6.8)
Stock-based compensation expense                                                   17
Restructuring costs                                                               9.1
Loss on investments, net                                                            0
Other                                                                             3.1
Changes in operating assets and liabilities:
Accounts receivable                                                              (8.7)
Inventories                                                                       71.2
Accounts payable                                                                 (5.2)
Income taxes                                                                     (5.3)
Pension obligation                                                               (0.3)
Other                                                                              2.5
Net cash provided by operating activities                                       515.7
Cash flows from investing activities:
Property, plant and equipment additions                                     (119.9)
Purchases of investments                                                     (25.1)
Proceeds from sale of investments                                               8.1
Acquisitions of businesses, net of cash acquired                                (6)
Purchases of technology                                                      (19.2)
Other, net                                                                      2.6
Net cash used in investing activities                                       (159.5)
Cash flows from financing activities:
Net issuance/(repayment) of short-term debt                                 (134.7)
Repayment of long-term debt                                                   (6.9)
Payment of dividends                                                         (70.7)
Treasury stock purchases                                                     (67.2)
Exercise of stock options                                                      23.3
Excess tax benefits from stock-based compensation                               5.9
Net cash used in financing activities                                       (250.3)
Effect of exchange rate changes on cash                                          14.8
Net change in cash and cash equivalents                                         120.7
Cash and cash equivalents at beginning of year                                  251.8
Cash and cash equivalents at end of year                                        372.5
Supplemental disclosures of cash flow information:
Income taxes paid                                                               145.4
Interest paid, net of capitalized interest                                      $13.3
12 Months Ended           12 Months Ended
 Dec. 31, 2008             Dec. 31, 2007


              $341.5                    $311.1


                   98.6                   97.8
                   18.1                 (21.7)
                   12.2                     19
                      0                      0
                    5.3                    0.2
                    1.7                  (2.6)

                 (4)                     (7.3)
              (37.5)                    (25.2)
              (12.2)                      26.8
               (0.1)                        25
              (20.6)                       2.6
                   1                     (8.7)
                404                        417

              (89.9)                    (77.6)
               (1.1)                      (8.6)
                11.6                        8.8
               (6.1)                    (67.6)
               (1.3)                      (5.4)
                 0.1                        1.4
              (86.7)                     (149)

               270.5                      61.8
                (90)                    (69.7)
              (65.4)                      (60)
             (421.2)                   (184.3)
                23.8                      32.4
                 8.4                       7.8
             (273.9)                     (212)
              (29.2)                          7.8
                14.2                         63.8
                  237.6                     173.8
                  251.8                     237.6

                  120.2                     113.9
                  $23.1                     $29.6
     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
                                                     12 Months Ended
                                                      Dec. 31, 2009
                                                       USD / shares

                                                  NOTE 1: SUMMARY OF
                                                  SIGNIFICANT ACCOUNTING
                                                  POLICIES Nature of
                                                  Operations Sigma-Aldrich
                                                  Corporation (the Company)
                                                  develops, manufactures,
                                                  purchases and distributes a
                                                  broad range of high quality
                                                  biochemicals and organic
                                                  chemicals throughout the
                                                  world. These chemical
                                                  products and kits are used in
                                                  scientific research, including
                                                  genomic and proteomic
                                                  research, biotechnology,
                                                  pharmaceutical development
                                                  and as key components in
                                                  pharmaceutical, diagnostic
                                                  and other high technology
                                                  manufacturing.
                                                  Principles of
                                                  Consolidation The
                                                  consolidated financial
                                                  statements include the
                                                  accounts of the Company
                                                  and all majority-owned
                                                  subsidiaries. All significant
                                                  intercompany accounts and
                                                  transactions have been
                                                  eliminated. Financial
                                                  Instruments The Company
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES        has no financial instruments
                                                  that have a materially
          ALLOWANCE FOR DOUBTFUL ACCOUNTS
                                               12 Months Ended
                                                Dec. 31, 2009
                                                 USD / shares

                                            NOTE 2: ALLOWANCE
                                            FOR DOUBTFUL ACCOUNTS
                                            Changes in the
                                            allowance for doubtful
                                            accounts for the years ended
                                            December31, 2009 and 2008
                                            are as follows:
                                               2009
                                            2008 Balance,
                                            beginning of year $
                                            4.1 $ 4.4
                                            Additions to reserves
                                             3.4 1.4
                                            Deductions from
                                            reserves 1.0
                                            1.7
                                            Balance, end of
                                            year $ 6.5 $
ALLOWANCE FOR DOUBTFUL ACCOUNTS             4.1
              INVENTORIES
                               12 Months Ended
                                Dec. 31, 2009
                                 USD / shares

                            NOTE 3:
                            INVENTORIES The
                            principal categories of
                            inventories at December31,
                            2009 and 2008 are as
                            follows:
                             2009 2008
                            Finished goods $
                            519.6 $ 566.9
                            Work in process
                            25.8 27.2
                            Raw materials
                            63.6 67.7
                                Total
                            $ 609.0 $ 661.8

                            Inventories are valued
                            at the lower of cost or
                            market. Costs for 74% of
                            inventories are determined
                            using a weighted average
                            actual cost method. Costs for
                            26% of inventories are
                            determined using the last-in,
                            first-out method. If the value
                            of all last-in, first-out
                            inventories had been
                            determined using the
                            weighted average actual cost
                            method, inventories would
                            have been $2.1, $1.3, and
INVENTORIES                 $0.7 higher than reported at
                            December31, 2009, 2008
                    INTANGIBLE ASSETS
                                           12 Months Ended
                                            Dec. 31, 2009
                                             USD / shares

                                        NOTE 4: INTANGIBLE
                                        ASSETS The Companys
                                        amortizable and
                                        unamortizable intangible
                                        assets at December31, 2009
                                        and 2008 are as follows:

                                          Cost
                                        Accumulated
                                        Amortization 2009
                                        2008 2009
                                        2008 Amortizable
                                        intangible assets:

                                        Patents $
                                        13.1 $ 16.7 $
                                        6.3 $ 6.6
                                        Licenses 38.1
                                         20.1 6.4
                                        5.8 Customer
                                        relationships 97.3
                                         95.1 29.9
                                         23.1 Technical
                                        knowledge 22.0
                                        21.1 7.5 5.6
                                        Other 12.9
                                         12.5 11.8
                                         11.4

                                        Total amortizable
                                        intangible assets $
INTANGIBLE ASSETS                       183.4 $ 165.5 $
                                        61.9 $ 52.5
                NOTES PAYABLE
                                    12 Months Ended
                                     Dec. 31, 2009
                                      USD / shares

                                NOTE 5: NOTES
                                PAYABLE Notes payable
                                consists of the following at
                                December31, 2009 and
                                2008:

                                December31, 2009
                                December31, 2008
                                 Out- standing
                                Weighted Average Rate
                                 Out- standing
                                Weighted Average Rate
                                Commercial
                                paper(1) $ 376.5
                                0.2 % $ 378.7
                                0.5 % $200.0
                                European revolving credit
                                facility, due March13,
                                2014(2)
                                 135.9 0.6 %
                                Sigma-Aldrich Korea
                                limited credit facility, due
                                June11, 2009(3)
                                  5.1 6.2 %
                                Other short-term
                                credit facilities(4)
                                  2.2 1.5 %

                                 Total notes
                                payable 376.5
                                0.2 % 521.9
NOTES PAYABLE                   0.6 % Plus
                                current maturities of long-
                 LONG-TERM DEBT
                                      12 Months Ended
                                       Dec. 31, 2009
                                        USD / shares

                                  NOTE 6: LONG-TERM
                                  DEBT Long-term debt
                                  consists of the following at
                                  December31, 2009 and
                                  2008:

                                   December31,
                                  2009 December31,
                                  2008 Out-
                                  standing Weighted
                                  Average Rate Out-
                                  standing Weighted
                                  Average Rate Senior
                                  notes, due September12,
                                  2010 (1) $ 100.0
                                   7.7 % $
                                  100.0 7.7 %
                                  Senior notes, due
                                  December5, 2011(2)
                                  100.0 5.1 %
                                   100.0 5.1
                                  % Other
                                    7.0 5.3
                                  %

                                  Total 200.0
                                   6.4 %
                                  207.0 6.4 %
                                  Less current
                                  maturities (100.0 )
                                  7.7 % (6.9 )
LONG-TERM DEBT                    5.3 %
      FINANCIAL DERIVATIVES AND RISK MANAGEMENT
                                                      12 Months Ended
                                                       Dec. 31, 2009
                                                        USD / shares

                                                  NOTE 7: FINANCIAL
                                                  DERIVATIVES AND RISK
                                                  MANAGEMENT The
                                                  Company transacts business
                                                  in many parts of the world
                                                  and is subject to risks
                                                  associated with changing
                                                  foreign currency exchange
                                                  rates. The Companys
                                                  objective is to minimize the
                                                  impact of foreign currency
                                                  exchange rate changes
                                                  during the period of time
                                                  between the original
                                                  transaction date and its cash
                                                  settlement. Accordingly, the
                                                  Company enters into forward
                                                  currency exchange contracts
                                                  in order to stabilize the value
                                                  of certain receivables and
                                                  payables denominated in
                                                  foreign currencies. None of
                                                  the contracts have been
                                                  designated as hedges for
                                                  accounting purposes. The
                                                  Company does not enter into
                                                  foreign currency transactions
                                                  for speculative trading
                                                  purposes. The principal
                                                  forward currency exchange
                                                  contracts are for the Euro,
FINANCIAL DERIVATIVES AND RISK MANAGEMENT         Swiss franc, Israeli shekel,
                                                  British pound, and Chinese
                    LEASE COMMITMENTS
                                           12 Months Ended
                                            Dec. 31, 2009
                                             USD / shares

                                        NOTE 8: LEASE
                                        COMMITMENTS The
                                        Company and its subsidiaries
                                        lease manufacturing, office
                                        and warehouse facilities and
                                        computer equipment under
                                        non-cancelable operating
                                        leases expiring at various
                                        dates. Rent expense was
                                        $39.3, $41.4, and $36.6 in
                                        2009, 2008 and 2007,
                                        respectively. Minimum rental
                                        commitments for non-
                                        cancelable leases in effect at
                                        December31, 2009, are as
                                        follows:
                                        2010 $
                                        37.0 2011
                                        29.0 2012
                                        21.8 2013
                                        13.6 2014
                                        10.4 2015 and
                                        thereafter 16.0
LEASE COMMITMENTS
               RESTRUCTURING ACTIVITIES
                                              12 Months Ended
                                               Dec. 31, 2009
                                                USD / shares

                                          NOTE 9:
                                          RESTRUCTURING
                                          ACTIVITIES In 2009 the
                                          Company committed to a
                                          restructuring plan that
                                          includes exit activities at five
                                          manufacturing sites in the
                                          U.S. and Europe. The
                                          Company expects to
                                          complete these activities
                                          over the next 1218 months.
                                          These exit activities impact
                                          approximately 200
                                          employees and are intended
                                          to reduce the Companys
                                          fixed cost structure and
                                          better align its global
                                          manufacturing and
                                          distribution footprint.
                                          Additionally, in 2009 the
                                          Company initiated a
                                          voluntary retirement
                                          program that was accepted
                                          by approximately 90 eligible
                                          U.S. employees as part of its
                                          cost reduction and long-term
                                          profit enhancement
                                          initiatives. The Company
                                          expects to further reduce its
                                          workforce by approximately
                                          100 people, some of these
RESTRUCTURING ACTIVITIES                  actions have already
                                          occurred in 2010. The
               INCOME TAXES
                                 12 Months Ended
                                  Dec. 31, 2009
                                   USD / shares

                              NOTE 10: INCOME
                              TAXES The components
                              of income before income
                              taxes consisted of the
                              following for the years ended
                              December31:

                              2009 2008 2007
                              United States
                              operations $ 319.8
                              $ 321.4 $ 286.6
                              International
                              operations 169.8
                               168.1 151.0

                              Total income
                              before taxes $ 489.6
                              $ 489.5 $ 437.6

                              The provision for
                              income taxes consists of the
                              following for years ended
                              December31:

                              2009 2008
                              2007 Current:

                              Federal $
                              95.5 $ 91.6
                              $ 86.4 State
                              and local 7.9
INCOME TAXES                  7.2 7.4
                              International
       CONTINGENT LIABILITIES AND COMMITMENTS
                                                    12 Months Ended
                                                     Dec. 31, 2009
                                                      USD / shares

                                                NOTE 11: CONTINGENT
                                                LIABILITIES AND
                                                COMMITMENTS The
                                                Company is involved in legal
                                                proceedings generally
                                                incidental to its business, as
                                                described below:
                                                Insurance and Other
                                                Contingent Liabilities and
                                                Commitments The Company
                                                is a defendant in several
                                                lawsuits and claims related
                                                to the normal conduct of its
                                                business, including lawsuits
                                                and claims related to product
                                                liability and personal injury
                                                matters. The Company
                                                accrues for such liabilities
                                                when it is probable that
                                                future costs (including legal
                                                fees and expenses) will be
                                                incurred and such costs can
                                                be reasonably estimated.
                                                The Company has self-
                                                insured retention limits and
                                                has obtained insurance to
                                                provide coverage above the
                                                self-insured limits for product
                                                liability and personal injury
                                                claims, subject to certain
                                                limitations and exclusions.
CONTINGENT LIABILITIES AND COMMITMENTS          Reserves have been provided
                                                to cover expected payments
               COMMON STOCK
                                  12 Months Ended
                                   Dec. 31, 2009
                                    USD / shares

                              NOTE 12: COMMON
                              STOCK The Companys
                              2003 Long-Term Incentive
                              Plan (2003 LTIP), permits
                              the granting of incentive or
                              nonqualified stock options as
                              well as stock appreciation
                              rights, performance shares,
                              restricted stock and other
                              stock-based awards. The
                              2003 LTIP permits the
                              distribution of up to
                              11,000,000 shares of the
                              Companys common stock,
                              subject to increase for any
                              shares forfeited under the
                              other plans after the
                              effective date of the 2003
                              LTIP. Shares issued under
                              the 2003 LTIP may be
                              authorized and unissued
                              shares or treasury shares.
                              This plan permits the award
                              of non-qualified stock options
                              to those members of the
                              Board of Directors who are
                              not employees of the
                              Company. Under this plan, a
                              non-employee Director will
                              receive an initial option to
                              purchase 20,000 shares of
COMMON STOCK                  common stock on the date of
                              his or her initial election as a
         COMPANY OPERATIONS BY BUSINESS UNIT
                                                  12 Months Ended
                                                   Dec. 31, 2009
                                                    USD / shares

                                               NOTE 13: COMPANY
                                               OPERATIONS BY BUSINESS
                                               UNIT The Company is
                                               organized into four business
                                               units featuring the Research
                                               units of Essentials,
                                               Specialties and Biotech and
                                               the Fine Chemicals unit,
                                               SAFC, to align the Company
                                               with the customers it serves.
                                               The business unit structure is
                                               the Companys approach to
                                               serving customers and
                                               reporting sales rather than
                                               any internal division used to
                                               allocate resources. Net sales
                                               for the Companys business
                                               units are as follows:

                                                2009 2008
                                               2007 Research
                                               Essentials $ 417.5
                                               $ 420.9 $ 390.7
                                               Research Specialties
                                                793.4 824.1
                                                753.5
                                               Research Biotech
                                                332.3 332.2
                                                302.0

                                               Research
COMPANY OPERATIONS BY BUSINESS UNIT            Chemicals 1,543.2
                                                1,577.2
  PENSION AND OTHER POST-RETIREMENT BENEFIT PLANS
                                                       12 Months Ended
                                                        Dec. 31, 2009
                                                         USD / shares

                                                    NOTE 14: PENSION
                                                    AND OTHER POST-
                                                    RETIREMENT BENEFIT
                                                    PLANS The Company
                                                    maintains several retirement
                                                    plans covering substantially
                                                    all U.S. employees and
                                                    employees of certain
                                                    international subsidiaries.
                                                    Pension benefits are
                                                    generally based on years of
                                                    service and compensation.
                                                    The Company also maintains
                                                    post-retirement medical
                                                    benefit plans covering some
                                                    of its U.S. employees.
                                                    Benefits are subject to
                                                    deductibles, co-payment
                                                    provisions and coordination
                                                    with benefits available under
                                                    Medicare. The Company has
                                                    made a determination
                                                    regarding the effects of the
                                                    Medicare Prescription Drug,
                                                    Improvement and
                                                    Modernization Act of 2003
                                                    (the Act) that the
                                                    prescription drug benefits it
                                                    provides are actuarially
                                                    equivalent to the benefits
                                                    provided under the Act.
PENSION AND OTHER POST-RETIREMENT BENEFIT PLANS     The following chart
                                                    summarizes the Consolidated
                     EARNINGS PER SHARE
                                              12 Months Ended
                                               Dec. 31, 2009
                                                USD / shares

                                          NOTE 15: EARNINGS
                                          PER SHARE A
                                          reconciliation of basic and
                                          diluted earnings per share,
                                          together with the related
                                          shares outstanding for the
                                          years ended December31 are
                                          as follows:

                                          2009 2008 2007
                                          Net income available
                                          to common shareholders
                                          $ 346.7 $ 341.5
                                          $ 311.1

                                          Weighted average
                                          shares ($ In Millions)

                                          Basic shares
                                          121.9 126.3
                                          130.6 Effect of
                                          dilutive securities options
                                          outstanding 1.8
                                          2.5 2.5

                                          Diluted shares
                                           123.7 128.8
                                           133.1
                                            Net
                                          income per share Basic
                                          $ 2.84 $ 2.70
EARNINGS PER SHARE                        $ 2.38
                                            Net
                    SHARE REPURCHASES
                                            12 Months Ended
                                             Dec. 31, 2009
                                              USD / shares

                                        NOTE 16: SHARE
                                        REPURCHASES At
                                        December31, 2009 and
                                        December31, 2008, the
                                        Company had repurchased a
                                        total of 93.7million shares
                                        and 92.3million shares,
                                        respectively. On October20,
                                        2008, the Board of Directors
                                        authorized the repurchase of
                                        up to an additional
                                        10.0million shares under the
                                        existing repurchase program,
                                        to be available for purchase
                                        within three years, bringing
                                        the total authorization to
                                        100.0million shares. There
                                        were 121.7million shares
                                        outstanding as of
                                        December31, 2009. The
                                        Company expects to
                                        continue to offset the dilutive
                                        impact of issuing incentive
                                        compensation by future
                                        repurchases. Further, the
                                        Company may repurchase
                                        additional shares, but the
                                        timing and amount will
                                        depend on market conditions
                                        and other factors.

SHARE REPURCHASES
      ACCUMULATED OTHER COMPREHENSIVE INCOME
                                                  12 Months Ended
                                                   Dec. 31, 2009
                                                    USD / shares

                                               NOTE 17:
                                               ACCUMULATED OTHER
                                               COMPREHENSIVE INCOME
                                               Components of
                                               accumulated other
                                               comprehensive income, net
                                               of tax are as follows:


                                                ForeignCurrency
                                               TranslationAdjustment
                                               UnrealizedGain(Loss) on
                                               Securities Pensionand
                                               Post-Retirement Benefit
                                               Plans
                                               AccumulatedOther
                                               ComprehensiveIncome
                                               Balance,
                                               December31, 2006 $
                                               107.3 $ 4.1
                                               $ (30.7 ) $ 80.7
                                               Current period
                                               change 71.5
                                               (0.7 ) 8.4
                                               79.2

                                                 Balance,
                                               December31, 2007
                                               178.8 3.4
                                               (22.3 ) 159.9
                                               Current period
ACCUMULATED OTHER COMPREHENSIVE INCOME         change (86.4 )
                                                (6.0 ) (42.2
                    SUBSEQUENT EVENTS
                                           12 Months Ended
                                            Dec. 31, 2009
                                             USD / shares

                                        NOTE 18: SUBSEQUENT
                                        EVENTS The Company
                                        has evaluated events and
                                        transactions subsequent to
                                        December31, 2009 through
                                        February10, 2010, the date
                                        the financial statements
                                        were filed with the SEC as
                                        part of this Form 10-K. No
                                        events required recognition
                                        in the consolidated financial
                                        statements or disclosures by
SUBSEQUENT EVENTS                       the Company.
                     Document Information
                                               12 Months Ended
                                                Dec. 31, 2009
                                                 USD / shares

Document Type                               10-K
Amendment Flag                              false
Document Period End Date                    2009-12-31
                   Entity Information (USD $)
                                                   12 Months Ended
                                                    Dec. 31, 2009

Trading Symbol                                  SIAL
Entity Registrant Name                          SIGMA ALDRICH CORP
Entity Central Index Key                        0000090185
Current Fiscal Year End Date                    --12-31
Entity Well-known Seasoned Issuer               Yes
Entity Current Reporting Status                 Yes
Entity Voluntary Filers                         No
Entity Filer Category                           Large Accelerated Filer
Entity Common Stock, Shares Outstanding
Entity Public Float
Jan. 31, 2010          Jun. 30, 2009




         121,772,581
                             $5,927,659,830

								
To top